Trusted by 100,000+ International Patients
Prostate Cancer Treatment: Italy vs Spain
Cost, Quality & Recovery Compared
$16000
Italy Starting Cost
$5000
Spain Starting Cost
See how these top medical tourism destinations compare for Prostate Cancer Treatment.
| Comparison Factor | Italy | Spain | Winner |
|---|---|---|---|
| Average Cost (in USD) | 16000 - 32000 | 5000 - 20000 | Spain |
| Success Rate (Min and Max) | 88% – 96% | 90% - 97% | Spain |
| Advanced Technology | Advanced prostate cancer treatments, including robotic-assisted prostatectomy, IMRT/SBRT radiation therapy, MRI-guided biopsy, PET-CT imaging, hormone therapy, and targeted oncology treatments, are available in leading cancer centres. | Highly advanced prostate cancer care including robotic-assisted prostatectomy (Da Vinci systems), IMRT, IGRT, SBRT, proton therapy (in select centres), MRI fusion-guided biopsy, PSMA PET-CT imaging, focal therapy (HIFU, cryotherapy), and precision oncology treatments | Both Equal |
| JCI Accredited Hospitals | 20+ | 15+ | Italy |
| Visa Process | Schengen Medical Visa / Short-Stay Schengen Visa (Type C) | Schengen Medical Visa / Short-Stay Visa (typically 10–15 working days) | Both Equal |
*Costs are estimates and may vary based on hospital, complexity, and package inclusions. See detailed cost breakdown below
Understand exactly where your money goes. Both countries offer all-inclusive packages, but here's how the costs typically break down.
Best for Budget-Conscious Patients
Offered Package Price (Additional Cost Excluded)
Best for Flexible Donor Requirements
Offered Package Price (Additional Cost Excluded)
Want a personalized cost estimate based on your specific condition?
Get Your Free QuoteBoth Italy and Spain maintain world-class healthcare standards with internationally accredited hospitals and highly trained medical professionals.
Italy hosts internationally accredited cancer centres, including JCI-accredited hospitals, along with nationally recognised institutions that follow strict European oncology care standards.
Oncology centres in Italy report strong outcomes for prostate cancer treatment, supported by experienced urologic oncologists, advanced surgical and radiation technologies, and multidisciplinary cancer care approaches.
Healthcare in Italy is governed by stringent European Union and national regulations, ensuring CE-marked medical devices, approved cancer therapies, standardized clinical protocols, and high levels of patient safety and quality compliance.
Spain has internationally recognised hospitals, including JCI-accredited centres and facilities operating under strict European Union healthcare quality and oncology care standards
Spain reports excellent outcomes in prostate cancer treatment due to high surgical volumes, early detection programs, advanced radiotherapy techniques, and multidisciplinary cancer care
Healthcare is regulated under national and EU frameworks, with oversight from the Spanish National Health System and oncology networks ensuring patient safety, approved technologies, and ethical clinical practices
| Quality Metric | Italy | Spain |
|---|---|---|
Accredited Hospitals | 20+ | 15+ |
Average Success Rate | 90–95% | 90–95% |
Post-op / 1-year outcome signal | 88–93% | 88–94% |
Top Speciality Hubs | Milan, Rome, Bologna | Madrid, Barcelona, Valencia |
Both countries have highly qualified and experienced medical specialists trained at premier institutions worldwide. Here's what sets them apart.
Urologic oncologists, radiation oncologists, and multidisciplinary cancer specialists specialising in prostate cancer surgery, robotic prostatectomy, and precision oncology treatments.
High-volume cancer centres with experienced oncologists trained in advanced prostate cancer management, including surgery, radiation therapy, and systemic treatments.
Highly specialised urologic oncologists, robotic surgeons, and radiation oncologists experienced in advanced prostate cancer management, focal therapies, and precision oncology
High-volume cancer centres with internationally trained specialists, strong expertise in robotic prostatectomy, radiotherapy, and multidisciplinary cancer treatment pathways
All surgeons listed on Medigence are verified for their medical license, board certifications, hospital affiliations, and patient outcomes. We conduct background checks and regularly update our database to ensure you're connected with the best medical professionals.
Beyond medical excellence, your comfort during treatment matters. Compare the patient experience at top hospitals in both destinations.
World-class hospitals, exceptional value
Advanced oncology centres equipped with robotic surgical systems, modern radiation therapy units (IMRT, SBRT), PET-CT imaging, molecular diagnostics, and multidisciplinary cancer care units.
Luxury healthcare experience
Advanced oncology centres equipped with robotic surgery systems, high-precision radiation therapy units (IMRT, IGRT, SBRT), proton therapy (select centres), PET-CT imaging, molecular diagnostics, and integrated cancer care units
Plan your medical journey with confidence. Here's everything you need to know about travel, visas, and accommodation in both countries.
We provide end-to-end travel assistance including visa facilitation, airport pickups, hotel bookings near your hospital, and local support throughout your stay. Our patient coordinators handle all logistics so you can focus on recovery.
Understanding the recovery process helps you plan better. Here's what to expect after Prostate Cancer Treatment in both countries.
Advanced oncology ICU and monitoring
Regular PSA monitoring and medication management
Early recovery supported by minimally invasive robotic surgery
Remote oncology follow-up available
In-person follow-ups recommended at 3, 6, 12 months. Telemedicine available.
Advanced oncology ICU and monitoring
Regular PSA monitoring and medication management
Early recovery supported by minimally invasive robotic surgery
Remote oncology follow-up available
Comprehensive telemedicine follow-up program. Return visits at 6, 12 months if possible.
Prostate Cancer Treatment recipients require lifelong immunosuppressant medications. Ensure you have a plan for obtaining these medications and regular blood monitoring in your home country before traveling abroad for surgery.
Every medical procedure carries risks. We believe in complete transparency so you can make a fully informed decision about your Prostate Cancer Treatment journey.
Reduced through sterile surgical protocols and antibiotics.
Temporary urinary leakage may occur after surgery.
Possible nerve damage affecting erectile function.
Regular PSA monitoring helps detect recurrence early.
Temporary fatigue, nausea, or hormonal side effects.
The right choice depends on your specific situation. Here's a clear guide to help you decide which destination aligns with your needs.
Men diagnosed with localised or advanced prostate cancer are seeking advanced treatment options such as robotic prostatectomy, radiation therapy, hormone therapy, or targeted oncology care.
Men diagnosed with localised or advanced prostate cancer are seeking advanced treatment options such as robotic prostatectomy, radiation therapy, hormone therapy, or targeted oncology care.
Our medical tourism experts can analyze your case and recommend the best destination based on your medical history and budget.
Follow this step-by-step framework to make the right choice for your Prostate Cancer Treatment journey.
Assess cancer stage, PSA levels, and overall health before treatment planning.
Consider surgery, radiation therapy, medications, travel, and accommodation costs.
Patients typically stay 2–3 weeks abroad, depending on treatment type.
Provide PSA reports, biopsy results, MRI/CT scans, and oncology consultation records.
Plan long-term PSA monitoring and periodic teleconsultations for recovery tracking.
Let our medical tourism experts guide you through the process. We'll help you:
No obligation • Free consultation • Response within 24 hours
Surgical Oncologist
15 Years of Experience
Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute. View More
